**Core Concept:** Bacteriostatic drugs are substances that inhibit bacterial growth without killing the bacteria. In the context of tuberculosis (TB) treatment, these drugs target specific cellular processes in Mycobacterium tuberculosis to prevent its multiplication in the host organism.

**Why the Correct Answer is Right:** Pyrazinamide (PZA) is a bacteriostatic anti-tubercular drug. It works by inhibiting the enzyme pyrazinoate mono-phosphate synthetase, a critical enzyme in the purine biosynthesis pathway of M. tuberculosis. This inhibition leads to a decrease in the formation of nucleotides, which are essential for the pathogen's DNA replication and protein synthesis.

**Why Each Wrong Option is Incorrect:**

A. Streptomycin (SM) is a bactericidal drug, meaning it kills the bacteria directly. It acts on the bacterial ribosome, disrupting protein synthesis and causing cell death.

B. Isoniazid (INH) is a bacteriocidal drug, which kills the bacteria directly by inhibiting the enzyme mycobacterial pyruvate kinase, crucial for the pathogen's energy production.

C. Ethambutol (EMB) is a bacteriostatic drug, inhibiting mycobacterial arabinosyl-phosphate synthetase, an enzyme involved in the synthesis of arabinan, a component of the cell wall in M. tuberculosis.

D. Rifampicin (RIF) is a bactericidal drug, inhibiting the mycobacterial RNA polymerase enzyme, which is essential for transcription and ultimately leads to cell death.

**Clinical Pearl:** Understanding the mode of action of anti-tubercular drugs is crucial for effective treatment of tuberculosis. Knowing whether a drug is bacteriostatic or bactericidal helps in selecting the appropriate drug combination for a patient. The combination of bactericidal and bacteriostatic drugs ensures both immediate killing (bactericidal) and long-term control of bacterial growth (bacteriostatic). This combination helps prevent drug resistance and ensures successful treatment outcomes.